Ignite Creation Date:
2025-12-24 @ 2:49 PM
Ignite Modification Date:
2026-01-06 @ 10:06 PM
Study NCT ID:
NCT04520659
Status:
COMPLETED
Last Update Posted:
2025-08-22
First Post:
2020-08-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID/ΔM2-2/1030s, in RSV-Seronegative Infants and Children 6 to 24 Months of Age
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-16
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-18
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-13
First Submit QC Date:
None
Study First Post Date:
2020-08-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-07-16
Results First Submit QC Date:
None
Results First Post Date:
2025-08-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-05
Last Update Post Date:
2025-08-22
Last Update Post Date Type:
ACTUAL